Suda allowed US patent for Sildenafil products

SUD Fri, 16 Oct 2015, 01:00pm AEDT

Suda Limited, a leader in oro-mucosal drug delivery, today announces that the US Patent and Trademark Office has allowed SUDA’s first patent application for its sildenafil based products, SUD-003 and SUD-004, in the USA. The patent application (US 14/363,245) is titled: Oral Spray Formulations and Methods for Administration of Sildenafil. A patent directed to similar subject matter has already been granted in New Zealand and patent applications are pending in other jurisdictions.